View Older Stories View More Recent Stories
-
Truist is bullish on this Managed Healthcare stock
-
Truist is bullish on this Managed Healthcare stock
-
Elevance (ELV) PT Raised to $424 at Bernstein SocGen
-
Elevance (ELV) PT Raised to $399 at Guggenheim
-
Elevance (ELV) PT Raised to $364 at Leerink Partners
-
Elevance (ELV) PT Raised to $408 at Barclays
-
Elevance (ELV) PT Raised to $360 at Evercore ISI
-
Elevance Health Inc. (ELV) Tops Q1 EPS by $1.74, Beats on Revenue; Offers FY26 EPS Guidance
-
Wolfe Research sees managed care companies underearning targets by up to 400%
-
UnitedHealth Group (UNH) Reiterated at Overweight by Cantor Fitzgerald Amid Trough Margins
-
Evercore ISI Starts Elevance (ELV) at In Line
-
Elevance (ELV) Reiterated at Overweight by Cantor Fitzgerald While Remaining Consensus Long
-
Elevance Health (ELV) call put ratio 1 call to 1.1 puts into health insurers Medicare rate hike
-
Elevance Health (ELV) call put ratio 1 call to 1.1 puts into health insurers Medicare rate hike
-
Humana shares surge 12% on 2027 Medicare rate boost; UNH, CVS Rally
-
Humana (HUM), UnitedHealth Group (UNH) Spike: Medicare Finalizes 2.48% Rate Hike For Private Insurers In 2027
-
Elevance Health names six executives in leadership restructuring
-
Elevance (ELV) Reiterated at Overweight by Cantor Fitzgerald After Management Talks
-
CVS Health appoints former Elevance Health CFO to board
-
Elevance (ELV) PT Lowered to $384 at Bernstein Amid MA Sanctions
-
Elevance (ELV) PT Lowered to $350 at Mizuho
-
Elevance (ELV) PT Lowered to $375 at Wolfe Research
-
TD Cowen Reiterates Buy Rating on Elevance (ELV)
-
DataVault AI and Wellgistics Health Announce Plans to Expand Partnership to Include Healthcare Delivery Intellectual Property for Healthcare as a Service (HaaS) Blockchain-enabled Smart Contracts
-
Stocks expected to have increasing option volume: ELV CVS CNC OSCR CI HUM MOH UNH
-
Elevra Lithium signs supply deal with Mangrove Lithium for concentrate
-
RBC Capital Downgrades Elevance (ELV) to Sector Perform
-
Elevance (ELV) PT Lowered to $409 at Bernstein
-
Elevance Health flags earnings decline amid bleak Medicare Advantage proposal
-
Elevance Health Inc. (ELV) Tops Q4 EPS by 23c; offers outlook
-
Health insurers slide after 2027 Medicare Advantage payments proposal underwhelms
-
Elevance Health (ELV) call put ratio 1 call to 1 put
-
After-hours movers: Humana, UnitedHealth, CVS Health, Sanmina and more
-
Elevance (ELV) PT Raised to $414 at Guggenheim
-
Bernstein: Softening Safety Net Cuts Signal Tailwinds for Medicaid and Marketplace Names (CNC, MOH, ELV)
-
Wolfe Research Upgrades Elevance (ELV) to Outperform
-
Elevance (ELV) Reiterated at Overweight by Cantor Fitzgerald
-
Deutsche Bank Downgrades Elevance (ELV) to Hold
-
Elevance (ELV) PT Raised to $400 at TD Cowen, 'Best Ideas 2026'
-
Elevance Health (ELV) CFO sees Medicaid margin declining at least 125 bps in '26
-
Elevance (ELV) PT Lowered to $400 at Mizuho
-
Elevance (ELV) PT Lowered to $412 at Bernstein SocGen Group
-
Cantor Fitzgerald Reiterates Elevance (ELV) at Overweight: Cautious of '26 Medicaid Environment
-
Elevance (ELV) PT Raised to $350 at Leerink Partners
-
Bernstein SocGen Group Reiterates Outperform Rating on Elevance (ELV)
-
Elevance Health Inc. (ELV) Tops Q3 EPS by 108c
-
Elevance Health earnings preview: Wolfe sees conservative 2026 guidance as potential ‘bottom’
-
Elevance Health (ELV) call put ratio 2.6 calls to 1 put into quarter results
-
Elevance (ELV) PT Lowered to $420 at Bernstein SocGen Group
-
Cantor Fitzgerald Reiterates Neutral on Molina Healthcare (MOH), Highlights 2026 Stars Progress

